Tag Archives: EMR

October 9, 2012 by jcarufel

FDA Notice Effective October 1, 2012

Important FDA Notice Effective October 1, 2012

+ read more|read comments (0)

August 14, 2012 by Allison Scott

New Draft FDA Guidance: Refuse to Accept Policy for 510(k) Submissions

On August 13, 2012, FDA issued a draft guidance document that, when final, will superseded the existing “Refuse to Accept” guidance document.  The updated draft policy includes an early review against specific acceptance criteria and to inform the submitter within the …

+ read more|read comments (0)

August 14, 2012 by Allison Scott

FDA Issues Draft Pre-Submission Guidance; Includes Pre-510(k) Program

On July 13, 2012, FDA issued a draft guidance document regarding pre-submission interactions with the Agency.  This draft guidance will eventually supersede the March 1999, Blue Book Memorandum Pre-IDE Program: Issues and Answers. The Pre-IDE program has since evolved into …

+ read more|read comments (0)

August 6, 2012 by Allison Scott

FDA Withdraws 2011 Deciding When Guidance

On July 17, 2012, FDA withdrew the 2011 Draft Guidance for Industry and FDA Staff – 510(k) Device Modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device.  This was done in accordance with Section 510(n)(2)(B) …

+ read more|read comments (0)

August 6, 2012 by Allison Scott

FDA’s UDI Proposed Rule 2012

Scott Thiel of Anson has provided the following summary of FDA’s newly released proposed rule for a UDI system.  The concept for the system has been under development by FDA for several years and after several public interactions with Industry …

+ read more|read comments (0)

August 3, 2012 by Allison Scott

Remote Patient Monitoring Market to increase over $20B

A recent report estimates that the remote patient monitoring market will increase to over $20 Billion dollars by 2016 – that’s more than double what the market is today ($8.9B). Just in the last couple of years Anson has seen …

+ read more|read comments (0)

July 31, 2012 by Allison Scott

Would FDA agree with you?

The publication McKensey Quarterly for June 2012 “Why good companies create bad regulatory strategies” raises this same question. Most corporate executives would agree that having an effective regulatory strategy is important. However, what most companies are overlooking is the effect …

+ read more|read comments (0)

June 11, 2012 by Dane Stout

Human Factors Engineering: Bringing iPhone usability to medtech

A team of my fellow consultants from Anson  and I participated in a webcast session sponsored by RAPS last week on the highly critical topic of Human Factors in Medical Device Development.    The information presented, particularly a presentation by Dr. Molly …

+ read more|read comments (0)

March 12, 2012 by Dane Stout

Building the Cathedral of Personalized Medicine One Sample at a Time

Anson’s culture is one that puts high value and importance on giving back to the community and society as part of measuring its value return on business.   Anson employees are encouraged to give back to the community, and even have …

+ read more|read comments (0)

March 9, 2012 by Dane Stout

Anson Group is a Proud Sponsor of Kids Against Hunger

Did you know that every 6 seconds a child dies from hunger related disease?  Anson is proud to be a corporate sponsor for the first ever Zionsville area Kids Against Hunger packing event on March 10, 2012.   If you’re not …

+ read more|read comments (0)